Cambodia stakeholders discussed #EFFORT trial results and shorter radical cure for #PlasmodiumVivax—7-day high-dose #primaquine or single-dose #tafenoquine. Quantitative #G6PD testing + safety monitoring are key. link.springer.com/article/10.1...

🗨️ #APMEN TechTalks: Safety and effectiveness of new tools including single-dose #tafenoquine and short-course high-dose #primaquine 💊

📆 26 May 2025 | 🕛 12:00 PM (Singapore Time).

🔗 Register! 👉 shorturl.at/7Zdef

Study supports low-dose #primaquine for blocking #malaria spread in young children. Adding a low dose of a widely available antimalaria drug to artemisinin-based combination therapy (ACT) is as safe and effective...
www.malariaworld.org/news/study-s...

🚨New project publication 🚨

📄 A recent study by our Global Health EDCTP3-funded #MARCSEAfrica project explored the efficacy and safety of malaria drug #primaquine in reducing #malaria transmission in young children.

Learn more➡️ tinyurl.com/5esb6e54

#AntimalarialResistance
@ec.europa.eu

Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P fal... In patients with a G6PD activity of 70% or greater, high-dose short-course primaquine was safe and relatively well tolerated and reduced the risk of subsequent P vivax parasitaemia within 63 days by f...

High-Dose short course primaquine was safe and relatively well tolerated and reduced the risk of subsequent P vivax parasitaemia within 63 days by five fold in this RCT in Bangladesh, Indonesia and Ethiopian.

www.thelancet.com/journals/lan...

#lancet #malaria #primaquine #plasmodium #vivaxmalaria